Aeglea BioTherapeutics, Inc.
SEC Filing List
AGLE CIK: 0001636282
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 08/14/2026 | |||
| SCHEDULE 13G/A | 08/14/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Albers Jeffrey W. | Spyre Therapeutics, Inc. | 08/10/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/07/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/07/2026 | ||
| 4 | Statement of changes in beneficial owner... | Burrows Scott L | Spyre Therapeutics, Inc. | 08/05/2026 | |
| 4 | Statement of changes in beneficial owner... | Turtle Cameron | Spyre Therapeutics, Inc. | 08/05/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Spyre Therapeutics, Inc. | 08/04/2026 | ||
| 8-K | Current report filing | Spyre Therapeutics, Inc. | 08/04/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 08/03/2026 | ||
| No record found. | |||||
| Load More | |||||
